Spleen‐Targeting Biomimetic Hybrid Nanocarriers for Systemic Immune Reprogramming in Colitis: RBC Membrane Vesicle‐Fused Lipid Nanoparticles
Year: 2025
Type: article
Language: en
Topic: Immune cells in cancer
Authors and affiliations:
raw_author_name: Jun Kwon
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Hee Su Sohn
raw_affiliation_strings: Division of Pulmonary and Critical Care Medicine Department of Medicine Brigham and Women's Hospital  Boston MA 02115 USA
Harvard Medical School  Boston MA 02115 USA
Harvard Medical School, Boston, MA, 02115 USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115 USA
raw_author_name: Jong Sang Yoon
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: So Won Jeon
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Hee Gyeong Ko
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Min‐Ho Kang
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Research Institute for Controlled Biomaterials of Regulated Cell Death The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Jisun Lee
raw_affiliation_strings: Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Medical and Biological Sciences The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Jae‐Hwan Nam
raw_affiliation_strings: Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Medical and Biological Sciences The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662 Republic of Korea
raw_author_name: Louis T. Merriam
raw_affiliation_strings: Division of Pulmonary and Critical Care Medicine Department of Medicine Brigham and Women's Hospital  Boston MA 02115 USA
Harvard Medical School  Boston MA 02115 USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115 USA
Harvard Medical School, Boston, MA, 02115 USA
raw_author_name: Edy Y. Kim
raw_affiliation_strings: Division of Pulmonary and Critical Care Medicine Department of Medicine Brigham and Women's Hospital  Boston MA 02115 USA
Harvard Medical School  Boston MA 02115 USA
Harvard Medical School, Boston, MA, 02115 USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115 USA
raw_author_name: Han Young Kim
raw_affiliation_strings: Department of Biomedical‐Chemical Engineering The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biotechnology The Catholic University of Korea  Bucheon 14662 Republic of Korea
Research Institute for Controlled Biomaterials of Regulated Cell Death The Catholic University of Korea  Bucheon 14662 Republic of Korea
Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea